"The US Food and Drug Administration (FDA) has approved Akorn Inc's phenylephrine hydrochloride ophthalmic solution (2.5% and 10%), the company has announced.
The alpha-1 adrenergic receptor agonist is commonly used by optometrists, ophtha"...
Alphagan-P Patient Information including How Should I Take
In this Article
- What is brimonidine ophthalmic (Alphagan-P)?
- What are the possible side effects of brimonidine ophthalmic (Alphagan-P)?
- What is the most important information I should know about brimonidine ophthalmic (Alphagan-P)?
- What should I discuss with my healthcare provider before using brimonidine ophthalmic (Alphagan-P)?
- How should I use brimonidine ophthalmic (Alphagan-P)?
- What happens if I miss a dose (Alphagan-P)?
- What happens if I overdose (Alphagan-P)?
- What should I avoid while using brimonidine ophthalmic (Alphagan-P)?
- What other drugs will affect brimonidine ophthalmic (Alphagan-P)?
- Where can I get more information?
What should I discuss with my healthcare provider before using brimonidine ophthalmic (Alphagan-P)?
You should not use this medication if you are allergic to brimonidine.
Do not use brimonidine ophthalmic if you have used an MAO inhibitor such as isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam), or tranylcypromine (Parnate) within the past 14 days.
Before using brimonidine ophthalmic, tell your doctor if you have:
- kidney disease;
- liver disease;
- heart disease or high blood pressure;
- circulation problems, such as Raynaud's syndrome or Buerger's disease; or
- a history of fainting or low blood pressure.
If you have any of these conditions, you may need a dose adjustment or special tests to safely use brimonidine ophthalmic.
FDA pregnancy category B. This medication is not expected to be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment.
It is not known whether brimonidine ophthalmic passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.
How should I use brimonidine ophthalmic (Alphagan-P)?
Use this medication exactly as prescribed by your doctor. Do not use it in larger amounts or for longer than recommended. Follow the directions on your prescription label.
Wash your hands before using the eye drops.
Do not use this medication while you are wearing contact lenses. This medication may contain a preservative that can be absorbed by soft contact lenses. Wait at least 15 minutes after using brimonidine before putting your contact lenses in.
To apply the eye drops:
- Tilt your head back slightly and pull down your lower eyelid to create a small pocket. Hold the dropper above the eye with the dropper tip down. Look up and away from the dropper as you squeeze out a drop, then close your eye.
- Gently press your finger to the inside corner of the eye (near your nose) for about 1 minute to keep the liquid from draining into your tear duct.
- If you use any other eye medications, wait about 5 minutes after using brimonidine eye drops before using the other medication.
- Do not allow the dropper tip to touch any surface, including the eyes or hands. If the dropper becomes contaminated it could cause an infection in your eye, which can lead to vision loss or serious damage to the eye.
Do not use the eye drops if the liquid has changed colors or has particles in it. Call your doctor for a new prescription.
Store the drops at room temperature away from heat and moisture. Keep the bottle tightly closed when not in use.
Additional Alphagan-P Information
- Alphagan-P Drug Interactions Center: brimonidine opht
- Alphagan-P Side Effects Center
- Alphagan-P Overview including Precautions
- Alphagan-P FDA Approved Prescribing Information including Dosage
Alphagan-P - User Reviews
Alphagan-P User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.